All News

    Reoperations May Offer Survival Benefit in Recurrent Glioblastoma

    February 8th 2025, 7:00pm

    Article

    When deciding if reoperation is an option in recurrent glioblastoma, factors like tumor location, therapy history and patient health should be considered.

    Braftovi Plus Erbitux With mFOLFOX6 May Improve Responses in BRAF V600E+ mCRC

    February 8th 2025, 3:00pm

    Article

    Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.

    Tafinlar/Mekinist Combo is Safe, Effective in Patients With Glioma

    February 7th 2025, 10:00pm

    Article

    Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among patients with gliomas.

    Tagrisso Associated With Cardiac Side Effects in Non-Small Cell Lung Cancer

    February 7th 2025, 8:00pm

    Article

    Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events and reduced overall survival.

    The Doctors Who Healed Me: My Journey With Colon Cancer and Gratitude

    February 7th 2025, 6:00pm

    Article

    My colon cancer journey showed me how compassionate doctors can change lives, as their kindness and care gave me strength and hope throughout my recovery.

    Randy Moss Shares Cancer Update, “Squid Game” Star Dies and More

    February 7th 2025, 4:00pm

    Article

    From the death of a Netflix actress due to stomach cancer complications to an NFL star sharing his chemo experience, here is this week’s cancer news.

    Neoadjuvant TKI Prior to Surgery Has Surgical Benefit in Non-Metastatic GIST

    February 7th 2025, 2:00pm

    Article

    Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less invasive or complex surgeries.

    Radiotherapy and Temozolomide Improve PFS in IDH-Wildtype Glioblastoma

    February 6th 2025, 10:00pm

    Article

    Concomitant radiotherapy plus temozolomide significantly increased progression-free survival versus radiotherapy alone in IDH-wildtype glioblastoma.

    Lumakras Combo May Replace SOC in Third-Line Treatment for mCRC

    February 6th 2025, 8:00pm

    Article

    Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated metastatic colorectal cancer.

    How a Cancer Diagnosis Wiped That Smug Look Off My Face

    February 6th 2025, 6:00pm

    Article

    It took a nightmare about a second cancer to shake me out of my complacency, and I nearly called 9 1 1.